Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Memphasys Ltd ( (AU:MEM) ).
Memphasys Limited has announced a significant upgrade to its contract with International Technical Legacy (ITL), increasing the contract value to A$390,000 and expanding its territory to include Turkey, a key IVF market in the EU. This expansion marks Memphasys’ first contracted revenues in the EU, contingent on CE Mark approval, and is part of a broader strategy to establish a scalable revenue model and strengthen its presence in the European IVF market.
More about Memphasys Ltd
Memphasys Limited operates in the biotechnology industry, focusing on reproductive technologies. The company is known for its Felix™ System, a pioneering technology in sperm preparation for assisted reproduction, and it targets markets with high demand for in vitro fertilization (IVF) solutions.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$9.92M
For a thorough assessment of MEM stock, go to TipRanks’ Stock Analysis page.